GSA Capital Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,360
Closed -$1.03M 1611
2024
Q4
$1.03M Buy
4,360
+1,500
+52% +$353K 0.08% 391
2024
Q3
$787K Buy
2,860
+1,018
+55% +$280K 0.06% 615
2024
Q2
$448K Buy
+1,842
New +$448K 0.03% 1039
2023
Q2
Sell
-1,042
Closed -$209K 1482
2023
Q1
$209K Buy
+1,042
New +$209K 0.02% 1237
2022
Q4
Sell
-1,239
Closed -$248K 1430
2022
Q3
$248K Buy
+1,239
New +$248K 0.03% 1058
2022
Q2
Sell
-2,554
Closed -$417K 1365
2022
Q1
$417K Buy
+2,554
New +$417K 0.06% 661
2021
Q3
Sell
-2,732
Closed -$463K 1388
2021
Q2
$463K Buy
2,732
+1,122
+70% +$190K 0.05% 680
2021
Q1
$227K Buy
+1,610
New +$227K 0.04% 819
2018
Q2
Sell
-2,573
Closed -$306K 1648
2018
Q1
$306K Buy
+2,573
New +$306K 0.02% 1301
2017
Q3
Sell
-7,206
Closed -$575K 1577
2017
Q2
$575K Buy
+7,206
New +$575K 0.04% 932
2016
Q4
Sell
-3,959
Closed -$268K 1724
2016
Q3
$268K Sell
3,959
-2,864
-42% -$194K 0.01% 1444
2016
Q2
$379K Buy
6,823
+3,099
+83% +$172K 0.02% 1250
2016
Q1
$234K Sell
3,724
-701
-16% -$44K 0.01% 1426
2015
Q4
$417K Sell
4,425
-42,499
-91% -$4M 0.02% 1269
2015
Q3
$3.77M Buy
46,924
+2,256
+5% +$181K 0.19% 71
2015
Q2
$5.35M Buy
44,668
+39,770
+812% +$4.77M 0.21% 46
2015
Q1
$511K Sell
4,898
-7,185
-59% -$750K 0.02% 1377
2014
Q4
$1.17M Buy
+12,083
New +$1.17M 0.08% 375
2014
Q3
Sell
-7,839
Closed -$495K 1697
2014
Q2
$495K Sell
7,839
-12,261
-61% -$774K 0.02% 1148
2014
Q1
$1.35M Buy
+20,100
New +$1.35M 0.1% 218